GConferenceGridThe Conference Catalogue · Vol. 2026Folio № 27DA53
Healthcare & Medical

Biotech Showcase 2026

B

iotech Showcase is the premier investor event for the biotech industry, serving as a platform for networking and partnership building between biotechnology and life sciences companies and investors. The event features in-person and digital partnering opportunities, as well as expert-led discussions, presentations, and exhibits. It provides an invaluable opp…

Visit the official site
50Voices
21Underwriters
22Exhibitors
0On the bill · sessions
81Companies · in total
§I

The Voices

Programmed at Biotech, in alphabetical order.
Alex Kadet
CBO · Gero
Alice Gilman
Co-Founder & COO · R3 Biotechnologies
Allison DeAngelis
Reporter · STAT
Amanda Kay
Senior Partner & Chief Business Development Officer · Flagship Pioneering
Annalee Armstrong
Senior Editor · BioSpace
Anthony Jarkowski, III
SVP, Primary Focus Lead, Head, Immuno-oncology · Astellas
Curt Herberts
Former President & COO · Kriya Therapeutics
David Ewing Duncan
Journalist, Author · Researcher
David Jenkins
SVP, Head, External Innovation and Research · Ipsen
Echo Hindle-Yang
Founder & CEO · MSQ Ventures
Eric Blouin
SVP, Oncology · Ipsos Healthcare Advisory
Eva Fortea-Verdejo
VP, Equity Research – Biotechnology · Wells Fargo Corporate & Investment Banking
Fritz Bittenbender
Board Chair, BIO & SVP · Genentech
Grace E. Colón
Board Chair, Aronora Biosciences, Bloom Science and Emm, Board Member · BIO and MIT
Grant Castor
SVP, Commercial Strategy & Operations · Sentynl
Gwendolyn Binder
President, Science and Technology · Cabaletta Bio
Hans Keirstead
Chairman · Immunis, Inc.
Ignacio Guerrero-Ros
VP · Russo Partners
James Healy
Managing Partner · Sofinnova Investments
Jay Hartenbach
President & COO · Diakonos Oncology
Jen Goldsack
CEO · Digital Medicine Society (DiMe)
Jessica Federer
Board Member · Angelini Ventures

— and 28 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.
AstellasPlatinum
CertaraPlatinum
Ergomed Clinical ResearchPlatinum
EVERSANAPlatinum
Foley Hoag LLPPlatinum
ICON plcPlatinum
Novo NordiskPlatinum
ParexelPlatinum
SciensusPlatinum
Syneos HealthPlatinum
WuXi AppTecPlatinum
Curia GlobalGold
IpsenGold
Avance ClinicalSilver
FortreaSilver
Hongene BiotechSilver
Jiuzhou PharmaceuticalSilver
NovotechSilver
Nucleus NetworkSilver
Worldwide Clinical TrialsSilver
XOMA RoyaltySilver
Intermission
Part the Second · For the Buyer

What does it mean when 81 companies show up — and 11 bet on three roles at once?

“81 companies. eleven are betting more than once.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
11All threespeak · spons · exh
10Sponsoringsponsor only
14Exhibitingexhibitor only
46Speakingspeaker only

The Triple-Threat

Avance Clinical·Certara·Curia Global·Ergomed Clinical Research·Hongene Biotech·Jiuzhou Pharmaceutical·Nucleus Network·WuXi AppTec·Astellas·Ipsen·Novo Nordisk

№ 02Fig. 02 — The Voices, by Seniority

72% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite1938%
  • Founder / Owner714%
  • VP-level918%
  • Director / Head of12%
  • Manager / Lead24%
  • Advisor / Investor36%
  • Other roles918%

Of 50 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01Avance ClinicalSp·SEx
  2. 02CertaraSp·PEx
  3. 03Curia GlobalSp·GEx
  4. 04Ergomed Clinical ResearchSp·PEx
  5. 05Hongene BiotechSp·SEx
  6. 06Jiuzhou PharmaceuticalSp·SEx
  7. 07Nucleus NetworkSp·SEx
  8. 08WuXi AppTecSp·PEx
  9. 09AstellasSp·P1V
  10. 10IpsenSp·G1V
  11. 11Novo NordiskSp·P1V
  12. 12EVERSANASp·P
  13. 13Foley Hoag LLPSp·P
  14. 14FortreaSp·S
№ 04Fig. 04 — By Tier
platinum11
52% of 21
gold2
10% of 21
silver8
38% of 21